Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IBIO

iBio (IBIO)

iBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:IBIO
DateTimeSourceHeadlineSymbolCompany
25/09/202406:11Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]AMEX:IBIOiBio Inc
21/09/202406:14Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:IBIOiBio Inc
21/09/202406:07Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
21/09/202406:05GlobeNewswire Inc.iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateAMEX:IBIOiBio Inc
03/09/202421:00GlobeNewswire Inc.iBio to Participate in Upcoming Investor ConferencesAMEX:IBIOiBio Inc
15/08/202407:24Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:IBIOiBio Inc
13/08/202406:30GlobeNewswire Inc.iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business DevelopmentAMEX:IBIOiBio Inc
07/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
07/08/202407:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:IBIOiBio Inc
26/07/202423:03Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/07/202407:05Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
10/07/202406:02Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
06/06/202406:10Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
04/06/202406:08Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
03/06/202421:00GlobeNewswire Inc.iBio Closes Sale of Manufacturing Facility in TexasAMEX:IBIOiBio Inc
20/05/202420:55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
14/05/202406:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
14/05/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
14/05/202406:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:IBIOiBio Inc
14/05/202406:08Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
14/05/202406:05GlobeNewswire Inc.iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate UpdateAMEX:IBIOiBio Inc
27/03/202422:00GlobeNewswire Inc.iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesAMEX:IBIOiBio Inc
27/03/202410:35GlobeNewswire Inc.iBio Announces $15.0 Million Private PlacementAMEX:IBIOiBio Inc
26/02/202423:59Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
26/02/202423:45GlobeNewswire Inc.iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaAMEX:IBIOiBio Inc
22/02/202408:55Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
20/01/202408:36Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
17/01/202400:15GlobeNewswire Inc.iBio Announces Participation in 23rd Annual PepTalk ConferenceAMEX:IBIOiBio Inc
11/01/202405:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:IBIOiBio Inc
09/01/202408:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
 Showing the most relevant articles for your search:AMEX:IBIO